Foreign Bonds, Fres...
Health Care: Health Services
Antares Pharma Inc. (ATRS: NASDAQ)
$4.09 0.03 | 0.74%
05/22/13 - 09:38 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -11.43M | -4.39M | -6.09M | -10.29M |
| Operating Gains/Losses | 119.43K | -30.00K | 56.90K | -70.51K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 310.81K | -1.30M | 214.28K | -239.44K |
| (Increase) Decrease in Inventories | -118.36K | -629.51K | 57.09K | -147.52K |
| (Increase) Decrease In Other Current Assets | 444.28K | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 724.80K | 365.52K | -100.81K | -201.16K |
| (Decrease) Increase In Other Current Liabilities | 687.30K | 406.82K | 716.16K | -324.41K |
| (Increase) Decrease In Other Working Capital | -3.36M | 1.76M | -2.39M | 4.42M |
| Other Non-Cash Items | 2.03M | 1.87M | 1.31M | 1.19M |
| Net Cash From Continuing Operations | -10.47M | -1.93M | -6.08M | -5.10M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -10.47M | -1.93M | -6.08M | -5.10M |
| Sale of Property, Plant & Equipment | 0.00 | 30.00K | 29.10K | 175.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -3.50M | -581.80K | -212.01K | -187.58K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -21.67M | -15.61M | -182.92K | -12.58K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 64.91M | 27.30M | 2.46M | 10.63M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -5.03M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -28.92K | -233.29K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 64.88M | 27.07M | 2.46M | 5.61M |
| Effect of Exchange Rate Changes | 1.07K | -25.96K | 87.59K | -31.87K |
| Net Change in Cash & Cash Equivalents | 32.74M | 9.51M | -3.71M | 462.79K |
Portfolios with ATRS
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserStocks
- ContributorStocks Under-$10 Moving Hig...
- UserGopher Gold
- UserSUPRATRADE FRIDAY GOLD STAR
- UserJohn Mero Portfolio 1
- UserMineandours
- UserForbes 25 Fastest Growing T...
Latest ATRS Headlines from TheStreet
- 2013 FDA Drug Approval Calendar 05.21.13 | 07:05 am
- 5 Stocks Under $10 Set to Soar 04.25.13 | 01:04 pm
- 'Mad Money' Lightning Round: Cisco Is Good 01.17.13 | 06:01 am
- 'Mad Money' Lightning Round: Take the Money and Run From AEO 12.04.12 | 06:12 am
- Cramer's 'Mad Money' Recap: Reasons to Worry 12.03.12 | 07:12 pm
- 5 Stocks Under $5 Moving Higher 09.18.12 | 02:09 pm
- Antares Pharma Inc. Stock Downgraded (ATRS) 08.10.12 | 05:08 am
- 7 Stocks Under $10 With Relative Strength 07.06.12 | 02:07 pm
- Antares Stock Hits New 52-Week High (ATRS) 06.26.12 | 10:06 am
- Symantec Buying Altiris 06.20.07 | 12:06 am
Press Releases for ATRS
- Antares Pharma Reports Fourth Quarter And Full Year 2012 Operating And Financial Results - Business Wire 03.13.13 | 07:03 am
- Antares Pharma To Host Fourth Quarter 2012 Call - Business Wire 03.06.13 | 07:03 am
- Antares Pharma Announces FDA Acceptance Of New Drug Application For OTREXUP™ - Business Wire 02.27.13 | 07:02 am
- Antares Pharma To Present At The Cowen And Company 33rd Annual Healthcare Conference - Business Wire 02.26.13 | 07:02 am
- Antares Pharma To Participate In The 2013 RBC Capital Markets’ Healthcare Conference - Business Wire 02.20.13 | 07:02 am
- Antares Pharma Announces Submission Of New Drug Application For OTREXUP™ - Business Wire 12.17.12 | 09:12 am
- Antares Pharma To Present At The Oppenheimer 23rd Annual Healthcare Conference - Business Wire 12.05.12 | 07:12 am
- Antares Pharma Announces Positive Results From Final MTX Medi-Jet™ Clinical Study - Business Wire 11.13.12 | 07:11 am
- Antares Pharma To Present At The Jefferies 2012 Global Healthcare Conference - Business Wire 11.08.12 | 07:11 am
- Antares Pharma Reports Third Quarter 2012 Financial And Operating Results - Business Wire 11.07.12 | 07:11 am
Partner Headlines for ATRS
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Antares Rallies Quickly And Confidently On Newest Developments - Seeking Alpha 01.11.13 | 08:01 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 12.05.12 | 09:12 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.20.12 | 09:11 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.16.12 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 11.14.12 | 09:11 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.09.12 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.24.12 | 09:10 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 10.04.12 | 09:10 am
- Morning Market Losers - Benzinga 10.03.12 | 09:10 am
